Navigation Links
TomoTherapy raises $223 million in IPO

Madison, Wis.- TomoTherapy has raised $223 million, the amount it had hoped to raise, in an initial public offering that was completed earlier today.

TomoTherapy, a portfolio company of Baird Venture Partners I, offered common stock at $19 per share, and expects to receive $185 million in net......

Full article >>> estors of Madison, first invested in TomoTherapy in March of 1999 and held the largest number of TomoTherapy shares prior to the IPO.

Related articles

TomoTherapy revises IPO money target

Hospital named for Madame Curie installs TomoTherapy syste......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 05/09/07


Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. TomoTherapy opens technical training center
3. TomoTherapy revises IPO money target
4. Hospital named for Madame Curie installs TomoTherapy system
5. TomoTherapy files registration statement for IPO
6. TomoTherapy to sell medical devices in India
7. TomoTherapy sees sustained market advantage
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... June, 23, 2016  The Biodesign Challenge (BDC), a ... ways to harness living systems and biotechnology, announced its ... in New York City . ... students, showcased projects at MoMA,s Celeste Bartos Theater during ... , MoMA,s senior curator of architecture and design, and ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... Florida , March 29, 2016 ... the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased ... in ink used in a variety of writing instruments, ... Buyers of originally created collectibles from athletes on LegacyXChange ... forensic analysis of the DNA. Bill ...
Breaking Biology News(10 mins):